BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9557745)

  • 21. Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.
    Johnston JB; Power C
    J Virol; 2002 Apr; 76(8):3626-36. PubMed ID: 11907202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
    Lathey JL; Brambilla D; Goodenow MM; Nokta M; Rasheed S; Siwak EB; Bremer JW; Huang DD; Yi Y; Reichelderfer PS; Collman RG
    J Leukoc Biol; 2000 Sep; 68(3):324-30. PubMed ID: 10985247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.
    Rana S; Besson G; Cook DG; Rucker J; Smyth RJ; Yi Y; Turner JD; Guo HH; Du JG; Peiper SC; Lavi E; Samson M; Libert F; Liesnard C; Vassart G; Doms RW; Parmentier M; Collman RG
    J Virol; 1997 Apr; 71(4):3219-27. PubMed ID: 9060685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands.
    Ghezzi S; Menzo S; Brambilla A; Bordignon PP; Lorini AL; Clementi M; Poli G; Vicenzi E
    Virology; 2001 Feb; 280(2):253-61. PubMed ID: 11162839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.
    Ogert RA; Lee MK; Ross W; Buckler-White A; Martin MA; Cho MW
    J Virol; 2001 Jul; 75(13):5998-6006. PubMed ID: 11390601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.
    Miller ED; Duus KM; Townsend M; Yi Y; Collman R; Reitz M; Su L
    J Virol; 2001 Sep; 75(18):8498-506. PubMed ID: 11507195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses.
    Rucker J; Edinger AL; Sharron M; Samson M; Lee B; Berson JF; Yi Y; Margulies B; Collman RG; Doranz BJ; Parmentier M; Doms RW
    J Virol; 1997 Dec; 71(12):8999-9007. PubMed ID: 9371556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between productive HIV-1 infection of macrophages and CCR5 utilization.
    Hung CS; Pontow S; Ratner L
    Virology; 1999 Nov; 264(2):278-88. PubMed ID: 10562492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.
    Peters PJ; Bhattacharya J; Hibbitts S; Dittmar MT; Simmons G; Bell J; Simmonds P; Clapham PR
    J Virol; 2004 Jul; 78(13):6915-26. PubMed ID: 15194768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.
    Sato H; Kato K; Takebe Y
    Virology; 1999 May; 257(2):491-501. PubMed ID: 10329559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cofactors for human immunodeficiency virus entry into primary macrophages.
    Collman RG; Yi Y
    J Infect Dis; 1999 May; 179 Suppl 3():S422-6. PubMed ID: 10099111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4.
    Naif HM; Cunningham AL; Alali M; Li S; Nasr N; Buhler MM; Schols D; de Clercq E; Stewart G
    J Virol; 2002 Apr; 76(7):3114-24. PubMed ID: 11884536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of nucleotide sequences in the V3 region in efficient replication of CCR5-utilizing human immunodeficiency virus type 1 in macrophages.
    Harada T; Tsunetsugu-Yokota Y; Koyanagi Y; Sata T; Kurata T; Kojima A
    Virology; 2002 Aug; 299(2):192-203. PubMed ID: 12202222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.
    Hung CS; Vander Heyden N; Ratner L
    J Virol; 1999 Oct; 73(10):8216-26. PubMed ID: 10482572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection.
    Sakaida H; Hori T; Yonezawa A; Sato A; Isaka Y; Yoshie O; Hattori T; Uchiyama T
    J Virol; 1998 Dec; 72(12):9763-70. PubMed ID: 9811711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor.
    Park IW; Koziel H; Hatch W; Li X; Du B; Groopman JE
    Am J Respir Cell Mol Biol; 1999 May; 20(5):864-71. PubMed ID: 10226056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein.
    Shimizu N; Haraguchi Y; Takeuchi Y; Soda Y; Kanbe K; Hoshino H
    Virology; 1999 Jul; 259(2):324-33. PubMed ID: 10388657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.